JP2024538707A5 - - Google Patents
Info
- Publication number
- JP2024538707A5 JP2024538707A5 JP2024520927A JP2024520927A JP2024538707A5 JP 2024538707 A5 JP2024538707 A5 JP 2024538707A5 JP 2024520927 A JP2024520927 A JP 2024520927A JP 2024520927 A JP2024520927 A JP 2024520927A JP 2024538707 A5 JP2024538707 A5 JP 2024538707A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163253964P | 2021-10-08 | 2021-10-08 | |
| US63/253,964 | 2021-10-08 | ||
| US202163290941P | 2021-12-17 | 2021-12-17 | |
| US63/290,941 | 2021-12-17 | ||
| US202263328524P | 2022-04-07 | 2022-04-07 | |
| US63/328,524 | 2022-04-07 | ||
| PCT/US2022/077772 WO2023060242A1 (en) | 2021-10-08 | 2022-10-07 | Il-2 prodrug |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024538707A JP2024538707A (ja) | 2024-10-23 |
| JPWO2023060242A5 JPWO2023060242A5 (https=) | 2025-09-24 |
| JP2024538707A5 true JP2024538707A5 (https=) | 2025-09-24 |
Family
ID=83978868
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024520927A Pending JP2024538707A (ja) | 2021-10-08 | 2022-10-07 | Ｉｌ－２プロドラッグ |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240374687A1 (https=) |
| EP (1) | EP4412712A1 (https=) |
| JP (1) | JP2024538707A (https=) |
| KR (1) | KR20240082401A (https=) |
| CA (1) | CA3233893A1 (https=) |
| WO (1) | WO2023060242A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025250977A1 (en) * | 2024-05-31 | 2025-12-04 | Werewolf Therapeutics, Inc. | Cancer therapy using il-2 prodrug |
| WO2026072455A1 (en) * | 2024-09-26 | 2026-04-02 | Werewolf Therapeutics, Inc. | Single domain human serum albumin antibodies |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20210130430A1 (en) * | 2018-05-14 | 2021-05-06 | Werewolf Therapeutics, Inc. | Activatable cytokine polypeptides and methods of use thereof |
| BR112022009110A2 (pt) | 2019-11-14 | 2022-07-26 | Werewolf Therapeutics Inc | Polipeptídeos de citocina ativáveis e métodos de uso destes |
-
2022
- 2022-10-07 WO PCT/US2022/077772 patent/WO2023060242A1/en not_active Ceased
- 2022-10-07 CA CA3233893A patent/CA3233893A1/en active Pending
- 2022-10-07 JP JP2024520927A patent/JP2024538707A/ja active Pending
- 2022-10-07 EP EP22797609.9A patent/EP4412712A1/en active Pending
- 2022-10-07 KR KR1020247014914A patent/KR20240082401A/ko active Pending
-
2024
- 2024-04-04 US US18/626,430 patent/US20240374687A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024538707A5 (https=) | ||
| JP2024534080A5 (https=) | ||
| JP2024531338A5 (https=) | ||
| BR102022025291A2 (https=) | ||
| CL2025003878A1 (es) | Sistemas de generación de energía a partir de fuentes geotérmicas y métodos de operación y construcción de los mismos. | |
| CL2025003587A1 (es) | Nuevos dispositivos de drenaje y su uso. | |
| BR102023014872A2 (https=) | ||
| BR102023010976A2 (https=) | ||
| BR102023009641A2 (https=) | ||
| BR102023008688A2 (https=) | ||
| BR102023007252A2 (https=) | ||
| BR102023005164A2 (https=) | ||
| BR102023001877A2 (https=) | ||
| BR102023000289A2 (https=) | ||
| BR102022026909A2 (https=) | ||
| BR102022023461A2 (https=) | ||
| BR202022009269U2 (https=) | ||
| BR202022005961U2 (https=) | ||
| BR202022001779U2 (https=) | ||
| BR202022000931U2 (https=) | ||
| BY13175U (https=) | ||
| BY13167U (https=) | ||
| BY23963C1 (https=) | ||
| CN307044396S (https=) | ||
| CN307044589S (https=) |